glp 1 long term safety As GLP-1 Use Expands, Long-Term Questions Remain Under Watch The GLP-1 Trap: Your Jumpstart

Alternative metrics: when BMI is not the whole story BMI is the gatekeeper, but it is not the only measure of whether you would benefit from GLP-1 therapy

Hims Pricing: Straightforward and Simple Pricing for Hims weight-loss medications depends on the treatment type and payment plan

Additional information Publishers note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Carbonell C, Mathew Stephen M, Ruan Y, Warkentin MT, Brenner DR

In the phase 2 NEJM trial, between 4% and 10% of people taking retatrutide reported feeling unusually tired, compared to just 4% in the placebo group